Loading asset research
Bright Minds Biosciences Inc. Common Stock
DRUGNasdaq · USD · StocksQuote as of · Exchange session not verified$51.80
-3.20%
Today
DRUG
Loading 1D prices…
Market cap
$508.3M
Volume
211K
52w high
$123.7552w low
$48.94Company profile
Bright Minds Biosciences Inc. Common Stock
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
CHICAGO, IL, United States
Employees
26
Fiscal year end
0930
CIK
1827401
Session & valuation
Open$53.33
Previous close$53.51
Day high$54.37
Day low$51.41
30-day avg. volume107.8K
Outstanding shares4.5M
Diluted EPS-$1.78
Latest annual period
P/E (trailing)-29.10
P/E (forward)-8.98
Price / book2.33
Beta-0.11
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PBYIPuma Biotechnology Inc Common Stock | $504.3M | $228.4M | +13.62% | $0.61 | -0.41% | Hold |
| INDPIndaptus Therapeutics Inc. Common Stock | $513M | $0.00 | — | -$21.58 | -3.00% | Unrated |
| KMDAKamada Ltd. Ordinary Shares | $503.2M | $180.5M | +11.19% | $0.35 | -1.25% | Buy |
| OCSOculis Holding AG Ordinary shares | $514.7M | — | — | -$1.89 | -1.49% | Buy |
| CBIOCrescent Biopharma Inc. Common Stock | $519.7M | $10.8M | +1.42% | -$12.81 | -1.90% | Buy |